The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 20, 2026
Filed:
Jul. 28, 2020
Takeda Pharmaceutical Company Limited, Osaka, JP;
Yuta Tanaka, Kanagawa, JP;
Yuta Tanaka, Kanagawa, JP;
Fumiaki Kikuchi, Kanagawa, JP;
Takeshi Yamamoto, Kanagawa, JP;
Minoru Nakamura, Kanagawa, JP;
Kazuaki Takami, Kanagawa, JP;
Masataka Murakami, Kanagawa, JP;
Masaki Daini, Kanagawa, JP;
Yasufumi Wada, Kanagawa, JP;
Keiko Kakegawa, Kanagawa, JP;
Takahito Kasahara, Kanagawa, JP;
Tomohiro Ohashi, Kanagawa, JP;
Junsi Wang, Kanagawa, JP;
Zenichi Ikeda, Kanagawa, JP;
Florian Puenner, Kanagawa, JP;
Masaki Seto, Kanagawa, JP;
Satoshi Mikami, Kanagawa, JP;
Minoru Sasaki, Kanagawa, JP;
Takeda Pharmaceutical Company Limited, Osaka, JP;
Abstract
The present invention provides a compound having a glucosylceramide synthase inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of lysosomal storage diseases (e.g., Gaucher's disease, Fabry's disease, GM1-gangliosidosis, GM2 activator deficiency, Tay-Sachs disease, Sandhoffs disease), neurodegenerative diseases (e.g., Parkinson's disease, Lewy body dementia, multiple-system atrophy) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.